Virtu Financial LLC Buys New Shares in Doximity, Inc. (NASDAQ:DOCS)

Virtu Financial LLC bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS) during the fourth quarter, HoldingsChannel reports. The firm bought 16,577 shares of the company’s stock, valued at approximately $885,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock worth $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. State Street Corp lifted its position in Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock worth $160,947,000 after purchasing an additional 88,922 shares during the period. Geode Capital Management LLC boosted its stake in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after buying an additional 472,565 shares in the last quarter. Los Angeles Capital Management LLC increased its holdings in Doximity by 33.7% in the 4th quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company’s stock valued at $46,466,000 after buying an additional 219,448 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Doximity by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company’s stock valued at $41,565,000 after buying an additional 25,523 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 37.40% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Needham & Company LLC lifted their target price on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, February 7th. The Goldman Sachs Group lifted their price objective on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Canaccord Genuity Group increased their target price on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a report on Friday, February 7th. KeyCorp decreased their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Finally, Mizuho increased their price objective on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Doximity presently has a consensus rating of “Moderate Buy” and a consensus target price of $64.22.

Doximity Stock Performance

NASDAQ DOCS opened at $66.39 on Tuesday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The stock has a market capitalization of $12.39 billion, a P/E ratio of 66.39, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The stock has a fifty day moving average of $64.76 and a 200-day moving average of $53.85.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.